Expression of p190 BCR-ABL fusion gene in a patient with chronic myeloid leukemia

A minority of chronic myeloid leukemia cases have breakpoints in the minor cluster region (m-bcr) of the BCR-ABL gene. We report on a patient with Ph-positive and m-bcr breakpoint at diagnosis. She was treated with hydroxyurea and interferon-alpha. Two years later, she developed a lymphoid blast crisis and died shortly after. We discuss herein the different forms of the BCR-ABL oncogene, its products, and the possible influence of them on the clinical outcome of patients with the disease.

Saved in:
Bibliographic Details
Main Authors: Carvalho,P. V. B., Lourenço,Gustavo J., Zocca,Maristela, Pagnano,K. B. B., Lorand-Metze,Irene, Souza,Carmino A. De, Lima,Carmen S. P.
Format: Digital revista
Language:English
Published: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular 2003
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842003000300009
Tags: Add Tag
No Tags, Be the first to tag this record!